OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?

Top 3 AI Stocks to Invest in Right Now

Fake shopping sprees and ‘happiness insurance’: The latest fintech apps reveal our financial anxieties

Is Apple’s foldable iPhone Duo worth $2,000? See how it stacks up against other foldable phones.

I gave my HomeExchange guest a 5-star review. Then I found heat marks all over my dining table. Do I call her out?

Inside the push to weaken Washington’s toughest financial watchdog

Scared to spend your retirement money? Here’s one way to get over the fear of running out.

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds

Stocks Moving the Most Today: Coupa Software, Horizon Therapeutics, Under Armour, and More

December 12, 2022

Coupa Software soars after it announces it will be acquired by private-equity firm Thoma Bravo in an $8 billion all-cash deal. Read More...

3rdPartyFeeds

INSIGHT-North Korean cyber spies deploy new tactic: tricking foreign experts into writing research for them

December 12, 2022

When Daniel DePetris, a U.S.-based foreign affairs analyst, received an email in October from the director of the 38 North think-tank commissioning an article...

3rdPartyFeeds • News

Need to Know: Retail capitulation may be a new year’s gift for the stock market, says this analyst

December 12, 2022

Retail investors are skittish about this market, and understandably. Our call of the day says that may only help lure back influential investors in the new...

3rdPartyFeeds • News

: Rivian says it won’t go forward with Mercedes-Benz deal three months after agreeing to it

December 12, 2022

Electric vehicle maker Rivian on Monday said it won't go forward with a plan to make electric vans in Europe with Mercedes-Benz, just three months after...

3rdPartyFeeds

Microsoft Stock Higher After Taking 4% Stake In London Stock Exchange Group

December 12, 2022

"We believe our partnership with Microsoft will transform the way our customers discover, analyze, and trade securities around the world," said LSE Group CEO...

3rdPartyFeeds

Stocks Moving the Most Today: Horizon Therapeutics, Coupa Software, Rivian, and More

December 12, 2022

Amgen is in advanced talks to buy drug company Horizon Therapeutics, according to a report from The Wall Street Journal. Read More...

3rdPartyFeeds

2 Semiconductor Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague

December 12, 2022

Two top-tier chipmakers stand out as screaming buys for the new year, while another widely held semiconductor stock is facing a mountain of headwinds. Read...

3rdPartyFeeds

Stocks Edge Higher, Week Ahead, Microsoft, Boeing, Amgen – Five Things To Know

December 12, 2022

Stock futures edge higher into end-of-year push; Week Ahead: Fed Meeting highlights crucial series of central bank decisions; Boeing shares rise on report of...

3rdPartyFeeds • News

Kelley Blue Book: Two-thirds of Ford dealers sign on to sell EVs

December 12, 2022

Ford gave its dealerships an ultimatum: Commit to selling electric cars at no-haggle pricing or lose the right to sell them. Not all of them are on board. Read...

3rdPartyFeeds • News

Kelley Blue Book: Tesla’s approval rating sinks into negative territory, survey finds

December 12, 2022

A survey that tests consumer perceptions of prominent brands indicates that more consumers now have a negative view of the EV maker than a positive view Read...

Previous 1 … 1,934 1,935 1,936 1,937 1,938 … 8,455 Next
Indices by TradingView

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.